Shingles Vaccine Cuts Heart Disease Risk by 12%

A shot meant to prevent a painful rash may be quietly saving hearts across America.

Researchers studying over 70,000 older adults discovered something unexpected about the modern shingles vaccine. People who received the newer version called Shingrix were significantly less likely to develop heart disease than those who got the older vaccine, with heart failure rates dropping by 12%.

The protective effect lasted for years and showed up strongest in the first few years after vaccination. Heart attacks dropped by 10%, and irregular heartbeats decreased as well.

This discovery happened almost by accident. When the US switched from an older shingles vaccine to Shingrix in late 2017, scientists saw a rare opportunity. They could compare two groups of people who both chose to get vaccinated, just with different versions, avoiding the usual problem where vaccinated people tend to be healthier overall.

They matched 36,460 people from each group by age, health status, and other factors. Over seven years, the group that received the newer vaccine experienced 9% less cardiovascular disease overall.

The question is why. Shingles itself can trigger inflammation that harms blood vessels, so preventing the disease helps. But researchers think there's more to the story.

The newer vaccine contains a powerful ingredient called AS01 that revs up the immune system. This booster might be doing something extra, possibly reducing harmful inflammation throughout the body, including the kind that damages hearts.

Why This Inspires

This isn't the first surprise from the shingles vaccine. Multiple studies have also linked it to lower dementia risk, with one showing people gained an extra 164 days without a dementia diagnosis.

These findings hint at something bigger. Vaccines designed for one purpose might be protecting us in ways we never imagined. The immune system connections between infections, inflammation, and chronic diseases run deeper than scientists previously understood.

Millions of Americans over 50 are already eligible for the shingles vaccine. Now they have one more reason to roll up their sleeves.

What started as protection against a painful rash might be guarding against heart attacks too, one shot at a time.